2 recruiting, 1 active not recruiting, 1 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Recruiting 2, Active not recruiting 1, Completed 1 |
Follow Disease Susceptibility: new trials by email Literature Review of Disease Susceptibility trials Research Report on Disease Susceptibility
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score Metoprolol Succinate, Beta-Blocker Polygenic Score, Illumina Infinium Global Diversity Array with Enhanced Pharmacogenomics (PGx) - Heart Failure With Reduced Ejection Fraction | Phase 4 | Recruiting | University of Michigan | 100 | 2026-12-01 | 2026-10-15 |
| Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention Rosuvastatin 20mg - PRS-based Primary Prevention of CVD | Phase 4 | Active not recruiting | Mikk JÜRISSON | 2714 | 2025-03-26 | 2026-05-13 |
| GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH oral semaglutide, Mixed Meal Tolerance Test (MMTT) - Genetic Predisposition, Metabolic Diseases | Phase 4 | Recruiting | Massachusetts General Hospital | 125 | 2024-03-12 | 2026-07-08 |
| Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING) Varenicline Tartrate or bupropion - Smoking Cessation, Genetic Predisposition | Phase 4 | Completed | University of Sao Paulo General Hospital | 361 | 2016-11-01 | 2022-12-21 |
Genetic Predisposition to Disease (2) · Genetic Risk Score (2) · Diabetes Mellitus, Type 2 (1) · Metabolic Diseases (1) · Smoking Cessation (1)
Disease Attributes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Genetic Predisposition to Disease (2) · Behavior (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Health Behavior (1) · Nutritional and Metabolic Diseases (1)
Bupropion (1) · Metoprolol (1) · Rosuvastatin Calcium (1) · Varenicline (1) · semaglutide (1)
Massachusetts General Hospital (1) · Mikk JÜRISSON (1) · University of Michigan (1) · University of Sao Paulo General Hospital (1)
United States (2) · Brazil (1) · Estonia (1)
Jaqueline R Scholz, MD.Phd (1) · Jasmine Luzum, PharmD, PhD (1) · Josephine Li, MD (1) · Margus Viigimaa, PhD (1)
PMID 38628555, PMID 38756738, PMID 42203295
K23DK131345 (1), R01HL178410 (1)